These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12209721

  • 1. Association of overexpressed proline-directed protein kinase F(A) with chemoresistance, invasion, and recurrence in patients with bladder carcinoma.
    Hsueh SF, Lai MT, Yang CC, Chung YC, Hsu CP, Peng CC, Fu HH, Cheng YM, Chang KJ, Yang SD.
    Cancer; 2002 Aug 15; 95(4):775-83. PubMed ID: 12209721
    [Abstract] [Full Text] [Related]

  • 2. Association of proline-directed protein kinase FA with tumorigenesis, invasion, and poor prognosis of human colon carcinoma.
    Chung YC, Chang KJ, Yang CC, Lai MT, Hsu CP, Hsueh SF, Peng CC, Fu HH, Chang YF, Yang SD.
    Cancer; 2002 Nov 01; 95(9):1840-7. PubMed ID: 12404276
    [Abstract] [Full Text] [Related]

  • 3. Suppression of proline-directed protein kinase F(A) expression inhibits the growth of human chronic myeloid leukaemia cells.
    Hsu CP, Hsueh SF, Yang CC, Yang SD.
    Br J Cancer; 2000 Apr 01; 82(8):1480-4. PubMed ID: 10780530
    [Abstract] [Full Text] [Related]

  • 4. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
    Hsu YC, Fu HH, Jeng YM, Lee PH, Yang SD.
    J Clin Oncol; 2006 Aug 10; 24(23):3780-8. PubMed ID: 16754939
    [Abstract] [Full Text] [Related]

  • 5. Antisense suppression of proline-directed protein kinase FA enhances chemosensitivity in human prostate cancer cells.
    Yang CC, Hsu CP, Yang SD.
    Clin Cancer Res; 2000 Mar 10; 6(3):1024-30. PubMed ID: 10741730
    [Abstract] [Full Text] [Related]

  • 6. Suppression of proline-directed protein kinase F(A) inhibits the malignant growth of human pancreatic ductal adenocarcinoma.
    Fu HH, Yang SD.
    Anticancer Res; 2004 Mar 10; 24(3a):1489-94. PubMed ID: 15274314
    [Abstract] [Full Text] [Related]

  • 7. Suppression of proline-directed protein kinase F(A) expression potentiates erythroid differentiation of human myeloid leukemia cells.
    Hsu CP, Yang CC, Yang SD.
    Cancer; 2000 Sep 01; 89(5):1004-11. PubMed ID: 10964330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of protein kinase FA/GSK-3alpha (a proline-directed kinase and a regulator of protooncogenes) with human cervical carcinoma dedifferentiation/progression.
    Yang SD, Yu JS, Lee TT, Ni MH, Yang CC, Ho YS, Tsen TZ.
    J Cell Biochem; 1995 Oct 01; 59(2):143-50. PubMed ID: 8904308
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
    Mizutani Y, Wada H, Fukushima M, Yoshida O, Nakanishi H, Li YN, Miki T.
    Cancer; 2004 Feb 15; 100(4):723-31. PubMed ID: 14770427
    [Abstract] [Full Text] [Related]

  • 11. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep 15; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 12. Suppression of proline-directed protein kinase F(A) potentiates apoptotic induction and greatly enhances chemosensitivity in human acute lymphoblastic leukemia cells.
    Hsu CP, Yang CC, Hsueh SF, Peng CC, Fu HH, Yang SD.
    Cancer; 2001 Oct 01; 92(7):1753-8. PubMed ID: 11745246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Overexpression of cellular activity and protein level of protein kinase FA/GSK-3 alpha correlates with human thyroid tumor cell dedifferentiation.
    Lee TT, Ho YS, Yu JS, Yang SD.
    J Cell Biochem; 1995 Aug 01; 58(4):474-80. PubMed ID: 7593269
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2005 Mar 01; 12(3):250-5. PubMed ID: 15828951
    [Abstract] [Full Text] [Related]

  • 16. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
    Margulis V, Shariat SF, Ashfaq R, Thompson M, Sagalowsky AI, Hsieh JT, Lotan Y.
    J Urol; 2007 Mar 01; 177(3):1163-8. PubMed ID: 17296438
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G, De Marco V, Gottardo F, Dalpiaz O, Bouygues V, Galfano A, Martignoni G, Patard JJ, Artibani W, Ficarra V.
    Cancer; 2007 Oct 15; 110(8):1715-22. PubMed ID: 17724728
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec 15; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.